Optimising therapeutic options for women's cancersO'SHAUGHNESSY, Joyce; VERGOTE, Ignace.European journal of cancer. Supplement (1990). 2007, Vol 5, Num 1, issn 1359-6349, 45 p.Serial Issue

New developments in gynecologic malignanciesOZOLS, Robert F; VERGOTE, Ignace.Seminars in oncology. 2006, Vol 33, Num 2, issn 0093-7754, 40 p., SUP6Serial Issue

Management of recurrent ovarian cancer with systemic therapyPOVEDA, Andrés.European journal of cancer. Supplement (1990). 2007, Vol 5, Num 1, pp 29-36, issn 1359-6349, 8 p.Article

The role of gemcitabine in first-line treatment of advanced ovarian carcinomaTHIGPEN, Tate.Seminars in oncology. 2006, Vol 33, Num 2, issn 0093-7754, S26-S32, SUP6Article

Developments in the systemic therapy of early-stage breast cancerO'SHAUGHNESSY, Joyce.European journal of cancer. Supplement (1990). 2007, Vol 5, Num 1, pp 3-10, issn 1359-6349, 8 p.Article

Systemic therapy for ovarian cancer : Current status and New TreatmentsOZOLS, Robert F.Seminars in oncology. 2006, Vol 33, Num 2, issn 0093-7754, S3-S11, SUP6Article

Clinical considerations in the optimisation of gemcitabine plus taxane as first-line treatment for metastatic breast cancerZIELINSKI, Christoph.European journal of cancer. Supplement (1990). 2007, Vol 5, Num 1, pp 17-22, issn 1359-6349, 6 p.Article

Pseudomyxoma peritonei associated with a mucinous ovarian tumor arising from a mature cystic teratoma. A case reportMARQUETTE, Sophie; AMANT, Frederic; VERGOTE, Ignace et al.International journal of gynecological pathology. 2006, Vol 25, Num 4, pp 340-343, issn 0277-1691, 4 p.Article

Report of an early stopped randomized trial comparing cisplatin vs. Cisplatin/Ifosfamide/ 5-fluorouracil in recurrent cervical cancerCADRON, Isabelle; JAKOBSEN, Anders; VERGOTE, Ignace et al.Gynecologic and obstetric investigation. 2005, Vol 59, Num 3, pp 126-129, issn 0378-7346, 4 p.Article

Controversies in surgery in ovarian cancer: what is its real role?VERGOTE, Ignace.European journal of cancer. Supplement (1990). 2003, Vol 1, Num 6, pp 115-125, issn 1359-6349, 11 p.Conference Paper

Unresolved issues in the chemotherapeutic management of gynecologic malignanciesMARKMAN, Maurie.Seminars in oncology. 2006, Vol 33, Num 2, issn 0093-7754, S33-S38, SUP6Article

Tamoxifen, screening and new oestrogen receptor modulatorsNEVEN, Patrick; VERGOTE, Ignace.Baillière's best practice & research. Clinical obstetrics & gynaecology. 2001, Vol 15, Num 3, pp 365-380, issn 1521-6934Article

Improving outcome in the first-line management of advanced ovarian cancerVERGOTE, Ignace; VAN GORP, Toon; CADRON, Isabelle et al.European journal of cancer. Supplement (1990). 2007, Vol 5, Num 1, pp 23-28, issn 1359-6349, 6 p.Article

Transition of epithelial toward mesenchymal differentiation during ovarian carcinosarcoma tumorigenesisAMANT, Frederic; VLOEBERGHS, Veerle; WOESTENBORGHS, Heidi et al.Gynecologic oncology (Print). 2003, Vol 90, Num 2, pp 372-377, issn 0090-8258, 6 p.Article

Pseudo-Meigs' syndrome caused by a hydropic degenerating uterine leiomyoma with elevated CA 125AMANT, Frédéric; GABRIEL, Charlotte; TIMMERMAN, Dirk et al.Gynecologic oncology (Print). 2001, Vol 83, Num 1, pp 153-157, issn 0090-8258Conference Paper

Chronic tumor necrosis factor-α infusion in gravid C57BL6/J mice accelerates adipose tissue development in female offspringLAMBIN, Suzan; VAN BREE, Rita; VERGOTE, Ignace et al.Journal of the Society for Gynecologic Investigation. 2006, Vol 13, Num 8, pp 558-565, issn 1071-5576, 8 p.Article

Gynécologie oncology in pregnancyAMANT, Frédéric; VAN CALSTEREN, Kristel; VERGOTE, Ignace et al.Critical reviews in oncology/hematology. 2008, Vol 67, Num 3, pp 187-195, issn 1040-8428, 9 p.Article

Management of platinum-sensitive recurrent ovarian cancerPFISTERER, Jacobus; LEDERMANN, Jonathan A.Seminars in oncology. 2006, Vol 33, Num 2, issn 0093-7754, S12-S16, SUP6Article

Altretamine (hexamethylmelamine) in the treatment of platinum-resistant ovarian cancer: a phase II studyKELDSEN, Nina; HAVSTEEN, Hanne; VERGOTE, Ignace et al.Gynecologic oncology (Print). 2003, Vol 88, Num 2, pp 118-122, issn 0090-8258, 5 p.Article

Phase II study of gemcitabine in recurrent platinum-and paclitaxel-resistant ovarian cancerD'AGOSTINO, Giuseppe; AMANT, Frederic; BERTELOOT, Patrick et al.Gynecologic oncology (Print). 2003, Vol 88, Num 3, pp 266-269, issn 0090-8258, 4 p.Article

A randomised, double-blind, phase II study of two doses of pemetrexed in the treatment of platinum-resistant, epithelial ovarian or primary peritoneal cancerVERGOTE, Ignace; CALVERT, Hilary; KANIA, Marek et al.European journal of cancer (1990). 2009, Vol 45, Num 8, pp 1415-1423, issn 0959-8049, 9 p.Article

Laparoscopy-assisted vaginal hysterectomy compared with abdominal hysterectomy in clinical stage I endometrial cancer : safety, recurrence, and long-term outcomeKALOGIANNIDIS, Ioannis; LAMBRECHTS, Sandrijne; AMANT, Frederic et al.American journal of obstetrics and gynecology. 2007, Vol 196, Num 3, pp 248-250, issn 0002-9378, 3 p.Article

Controversies of chemotherapy for the treatment of metastatic breast cancerCONTE, Pier Franco; BENGALA, Cannelo; GUARNERI, Valentina et al.European journal of cancer. Supplement (1990). 2007, Vol 5, Num 1, pp 11-16, issn 1359-6349, 6 p.Article

Intraperitoneal chemotherapy in ovarian cancer remains experimental. CommentaryGORE, Martin; DU BOIS, Dep Andreas; VERGOTE, Ignace et al.Journal of clinical oncology. 2006, Vol 24, Num 28, pp 4528-4533, issn 0732-183X, 6 p.Article

Quality of life considerations in gynecologic cancerPENSON, Richard T; WENZEL, Lari B; VERGOTE, Ignace et al.International journal of gynecology & obstetrics. Supplement. 2006, Vol 95, Num 1, issn 0924-8447, S247-S257Article